Raleigh – Collaborations Pharmaceuticals, Inc. (CPI) announced today that they have entered into an agreement with Stepan Company to license CPI’s MegaTox® machine learning software for predicting toxicology properties to aid their decision making and regulatory processes.
“We are honored to announce our first public licensee of our MegaTox software which we have developed with support from an SBIR from NIEHS.” MegaTox® provides curated machine learning models for ADME/Tox properties to scientists in chemical, consumer product, agrochemical, and pharmaceutical companies to enable them to predict properties and activities for molecules. The best-in-class machine learning algorithms are based upon over 25 years of ADME/Tox modelling research including not only human toxicology but also biodegradation, eco-toxicity and other properties of interest which can be used for read-across predictions. These machine learning models may assist in the regulatory decision-making process for molecules of commercial interest.
MegaTox is a curated data package that builds on the Assay Central® software platform for building bespoke machine learning models using datasets from dozens to hundreds of thousands of molecules.
“We look forward to working with Stepan Company to enable them to more efficiently make toxicity hazard decisions on small molecules that are of interest to them” said Sean Ekins, CEO, CPI.
Disclaimer
“Research reported in this publication was supported by the National Institute Of Environmental Health Sciences of the National Institutes of Health under Award Number 1R43ES033855-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
About Collaborations Pharmaceuticals, Inc.
Collaborations Pharmaceuticals, Inc.® has developed software for data curation and machine learning called Assay Central® (www.assaycentral.org) as well as curated model bundles in MegaTox®, MegaTrans® and MegaPredict®. Most recently we have developed MegaSyn and UV-adVISor. CPI performs research and development on innovative therapeutics for multiple rare and neglected diseases and is located in laboratories in the NC State Incubator on the Centennial campus. We have considerable experience with preclinical and computational approaches to drug discovery and toxicity prediction. For more information, please visit http://www.collaborationspharma.com/
Sean Ekins, Ph.D., D.Sc.
CEO and Founder,
Collaborations Pharmaceuticals, Inc.
840 Main Campus Drive, Lab 3510
Raleigh, NC 27606
Tel 215-687-1320
About Stepan Company
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.
Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.
The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com.
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com.
Contact: Luis E. Rojo 847-446-7500